Pricing principles

Prescription Medicine Pricing: Advancing Responsible Leadership

At Sanofi, we have a longstanding commitment to fostering healthcare systems that make our treatments accessible and affordable to those in need.

Our Pricing Principles detail how we price our medicines and advocate for policy solutions to make the system work better for patients and their care teams. By publishing results over the past decade, we aim to build transparency and enable a more informed U.S. dialogue on medicine pricing.

The Three Pillars of Our Pricing Principles

Clear Rationale for Pricing:

We take a holistic approach to pricing new medicines, considering patient perspectives, clinical value compared to existing treatments, economic impact on overall healthcare costs, social contributions to quality of life, and system-wide affordability.

Review our 2025 data

Reporting of U.S. Pricing Actions:

We balance innovation and responsibility to help contain healthcare spending. We adhere to responsible pricing principles for list price adjustments and annually disclose any mandatory supplemental rebates triggered by those actions.

Review our 2025 data

Continued Transparency in the U.S.:

We annually disclose our average aggregate U.S. list and net price changes to foster better-informed discussions about patient access and affordability.

Review our 2025 data

Featured Brief

NEW The Unintended Consequences of Price Controls

Price controls are increasingly shaping the conversation around drug pricing and may have unintended consequences for innovation, patient access, and the future of medical discovery.

Learn more